Adverse drug reactions (ADRs) are types of adverse drug events (ADEs). ADEs include ADRs, medication errors, and other drug-related problems. ADEs are the negative
MoreAn aptamer is a single-stranded oligonucleotide that binds to and inactivates a specific target, usually a protein. Several properties of
MoreBiopharmaceuticals are defined as substances produced in living systems by biotechnology and used for therapeutic purposes or in vivo diagnostics.
MoreTherapeutic antibodies are precisely targeted biopharmaceuticals that recognize and bind to a cell surface antigen and then trigger a biological
MoreFor a better understanding of the lifecycle of a drug, consider the following aspects of the afterlives of APIs: where
MoreGreen pharmacy is the design of pharmaceutical products and processes that eliminate or reduce significantly the use and generation of
MoreA term coined by Gary Henderson, contemporary pharmacologist, meaning an illicitly produced drug of abuse whose structure is a modification
MorePharmacogenomics is the study of the effect of an individual’s genetic inheritance, their genome, on the body’s response to drugs.
MoreThe field of pharmacogenetics, which is about 40 years old, is the study of genetically determined variability in the response
MoreThe goal for most drug delivery systems is rapid dissolution of drug after administration; such products are called immediate release
MoreNiosomes are non-ionic surfactant vesicles and it present low production cost, greater stability, and resultant ease of storage. Niosomes are
More